Literature DB >> 11916247

Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.

Francis J Burrows1, Martin Gore, W Russell Smiley, Martha Y Kanemitsu, Douglas J Jolly, Susana B Read, Thomas Nicholas, Carol A Kruse.   

Abstract

An important consequence of the suicide gene therapeutic paradigm is the phenomenon of bystander cell killing, the death of adjacent tumor cells not transduced with the thymidine kinase (TK) gene from herpes simplex virus (HSV) after treatment with the antiviral drug, ganciclovir (GCV). Evidence from quantitative in vitro assays of glioma cell lines suggest that both murine and human gliomas are similar in expressing high sensitivity to the bystander effect. In five of six glial tumors examined, the presence of only 5% of HSV-TK-expressing transduced cells in the culture resulted in >90% tumor cell death/stasis after addition of GCV. Several lines of evidence support gap junction intercellular communication (GJIC) as important in the bystander effect. In vitro metabolic assays, performed with GCV in the medium, indicated that more tumor burden was reduced when culture conditions supported cell-cell contact of parental and HSV-TK-transduced cells. Additionally, a double dye transfer assay showed that cell communication through the gap junction is greatest for glioma, less for melanoma, and much less for colorectal carcinoma cell lines. In vitro metabolic assays with mixtures of TK+/TK- homologous tumor cells confirmed that glioma cell lines were more susceptible to bystander killing than melanomas. Assays with chimeric tumor mixtures of TK+/TK - cells showed that the level of the bystander killing obtained was characteristic of the TK-bystander cells. The in vitro findings were confirmed in vivo with GCV-treated homologous and chimeric tumors composed of TK+/TK- cells. Day 21 mean tumor volumes (MTVs) indicated the growths obtained were characteristic of the bystander activity reflective of the nontransduced cell population. Furthermore, nontransduced, high-GJIC cells in a chimeric tumor mass appeared to effectively bridge between transduced tumor cells and poorly communicating nontransduced cells. Finally, the importance of a gap junction protein, such as connexin-43, in facilitating the bystander effect was demonstrated with the HT29 low-GJIC cell line. When the TK-nontransduced cell population expressed connexin-43, a better bystander kill was achieved compared to the parental counterpart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916247     DOI: 10.1038/sj.cgt.7700401

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  14 in total

Review 1.  Gap junction hemichannels in astrocytes of the CNS.

Authors:  J C Sáez; J E Contreras; F F Bukauskas; M A Retamal; M V L Bennett
Journal:  Acta Physiol Scand       Date:  2003-09

Review 2.  Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue.

Authors:  Jorge E Contreras; Helmuth A Sánchez; Loreto P Véliz; Feliksas F Bukauskas; Michael V L Bennett; Juan C Sáez
Journal:  Brain Res Brain Res Rev       Date:  2004-12

Review 3.  Clinical trials with retrovirus mediated gene therapy--what have we learned?

Authors:  Nikolai G Rainov; Huan Ren
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

Review 4.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 5.  The Role of Oncolytic Viruses in the Treatment of Melanoma.

Authors:  Claire-Audrey Y Bayan; Adriana T Lopez; Robyn D Gartrell; Kimberly M Komatsubara; Margaret Bogardus; Nisha Rao; Cynthia Chen; Thomas D Hart; Thomas Enzler; Emanuelle M Rizk; Jaya Sarin Pradhan; Douglas K Marks; Larisa J Geskin; Yvonne M Saenger
Journal:  Curr Oncol Rep       Date:  2018-08-25       Impact factor: 5.075

6.  Experimental study of thymidine kinase gene therapy of neuroblastoma in vitro and in vivo.

Authors:  Xun Bi; Jing-Zhe Zhang
Journal:  Pediatr Surg Int       Date:  2003-07-05       Impact factor: 1.827

7.  Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.

Authors:  Sung Hyun Yang; Tae Keun Oh; Seung Taik Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer.

Authors:  Martin Trepel; Charlotte A Stoneham; Hariklia Eleftherohorinou; Nicholas D Mazarakis; Renata Pasqualini; Wadih Arap; Amin Hajitou
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

9.  Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.

Authors:  Andrea Lisco; Christophe Vanpouille; Egor P Tchesnokov; Jean-Charles Grivel; Angélique Biancotto; Beda Brichacek; Julie Elliott; Emilie Fromentin; Robin Shattock; Peter Anton; Robert Gorelick; Jan Balzarini; Christopher McGuigan; Marco Derudas; Matthias Götte; Raymond F Schinazi; Leonid Margolis
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

10.  Do there exist synergistic antitumor effects by coexpression of herpes simplex virus thymidine kinase with cytokine genes on human gastric cancer cell line SGC7901?

Authors:  Jian-Hua Zhang; Ming-Xi Wan; Jia-Ying Yuan; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.